209 related articles for article (PubMed ID: 30339815)
1. Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity.
Wang J; Tang Z; Zhang Y; Qiu C; Zhu L; Zhao N; Liu Z
Eur J Pharmacol; 2019 Jan; 842():118-124. PubMed ID: 30339815
[TBL] [Abstract][Full Text] [Related]
2. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway.
Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR
Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.
Guo T; Cornea RL; Huke S; Camors E; Yang Y; Picht E; Fruen BR; Bers DM
Circ Res; 2010 Jun; 106(11):1743-52. PubMed ID: 20431056
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system.
Okatan EN; Tuncay E; Turan B
J Nutr Biochem; 2013 Dec; 24(12):2110-8. PubMed ID: 24183307
[TBL] [Abstract][Full Text] [Related]
6. Matrine-Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species-Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling.
Liu Z; Lv Y; Zhang Y; Liu F; Zhu L; Pan S; Qiu C; Guo Y; Yang T; Wang J
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29197828
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase RNA-like endoplasmic reticulum kinase (PERK)/calcineurin signaling is a novel pathway regulating intracellular calcium accumulation which might be involved in ventricular arrhythmias in diabetic cardiomyopathy.
Liu Z; Cai H; Zhu H; Toque H; Zhao N; Qiu C; Guan G; Dang Y; Wang J
Cell Signal; 2014 Dec; 26(12):2591-600. PubMed ID: 25152364
[TBL] [Abstract][Full Text] [Related]
8. FKBP12 activates the cardiac ryanodine receptor Ca2+-release channel and is antagonised by FKBP12.6.
Galfré E; Pitt SJ; Venturi E; Sitsapesan M; Zaccai NR; Tsaneva-Atanasova K; O'Neill S; Sitsapesan R
PLoS One; 2012; 7(2):e31956. PubMed ID: 22363773
[TBL] [Abstract][Full Text] [Related]
9. TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle.
Zhou X; Park KH; Yamazaki D; Lin PH; Nishi M; Ma Z; Qiu L; Murayama T; Zou X; Takeshima H; Zhou J; Ma J
Circ Res; 2020 Feb; 126(4):417-435. PubMed ID: 31805819
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action.
Ashna A; van Helden DF; Dos Remedios C; Molenaar P; Laver DR
Mol Pharmacol; 2020 Apr; 97(4):250-258. PubMed ID: 32015008
[TBL] [Abstract][Full Text] [Related]
11. Matrine inhibits advanced glycation end products-induced macrophage M1 polarization by reducing DNMT3a/b-mediated DNA methylation of GPX1 promoter.
Cui Q; Du H; Ma Y; Wang T; Zhu H; Zhu L; Pan S; Min N; Wang X; Liu Z
Eur J Pharmacol; 2022 Jul; 926():175039. PubMed ID: 35597264
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor modification and regulation by intracellular Ca
Walweel K; Molenaar P; Imtiaz MS; Denniss A; Dos Remedios C; van Helden DF; Dulhunty AF; Laver DR; Beard NA
J Mol Cell Cardiol; 2017 Mar; 104():53-62. PubMed ID: 28131631
[TBL] [Abstract][Full Text] [Related]
13. Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy.
Zhang Y; Cui L; Guan G; Wang J; Qiu C; Yang T; Guo Y; Liu Z
Mol Med Rep; 2018 Jan; 17(1):1775-1781. PubMed ID: 29138820
[TBL] [Abstract][Full Text] [Related]
14. K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association.
Hunt DJ; Jones PP; Wang R; Chen W; Bolstad J; Chen K; Shimoni Y; Chen SR
Biochem J; 2007 Jun; 404(3):431-8. PubMed ID: 17313373
[TBL] [Abstract][Full Text] [Related]
15. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
[TBL] [Abstract][Full Text] [Related]
16. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias.
Xiao J; Tian X; Jones PP; Bolstad J; Kong H; Wang R; Zhang L; Duff HJ; Gillis AM; Fleischer S; Kotlikoff M; Copello JA; Chen SR
J Biol Chem; 2007 Nov; 282(48):34828-38. PubMed ID: 17921453
[TBL] [Abstract][Full Text] [Related]
17. Matrine suppresses AGE-induced HAEC injury by inhibiting ROS-mediated NRLP3 inflammasome activation.
Zhang Y; Yang X; Qiu C; Liu F; Liu P; Liu Z
Eur J Pharmacol; 2018 Mar; 822():207-211. PubMed ID: 29374549
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca release and pathologically alter, RyR structure and calmodulin affinity.
Oda T; Yang Y; Uchinoumi H; Thomas DD; Chen-Izu Y; Kato T; Yamamoto T; Yano M; Cornea RL; Bers DM
J Mol Cell Cardiol; 2015 Aug; 85():240-8. PubMed ID: 26092277
[TBL] [Abstract][Full Text] [Related]
19. Matrine blocks AGEs- induced HCSMCs phenotypic conversion via suppressing Dll4-Notch pathway.
Liu Z; Wang Y; Zhu H; Qiu C; Guan G; Wang J; Guo Y
Eur J Pharmacol; 2018 Sep; 835():126-131. PubMed ID: 30063915
[TBL] [Abstract][Full Text] [Related]
20. Matrine pre-treatment suppresses AGEs- induced HCSMCs fibrotic responses by regulating Poldip2/mTOR pathway.
Ma W; Xu J; Zhang Y; Zhang H; Zhang Z; Zhou L; Wang X; Liu H; Chen Y; Du P; Min N; Liu Z; Yin Y
Eur J Pharmacol; 2019 Dec; 865():172746. PubMed ID: 31634459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
